In clinical studies, the medication showed an average weight reduction of 3-9% of body weight
65%+ is a conservative estimate for commercial insurance)
Current evidence and clinical guidance indicate no direct pharmacokinetic or pharmacodynamic interaction between ibuprofen and semaglutide
More serious but rare adverse effects include pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), and acute kidney injury, which require prompt medical evaluation if symptoms develop
The clinic emphasizes personalized care, focusing on the root causes of weight issues to foster long-term health transformations
This includes eating a balanced diet, staying hydrated, getting regular exercise, and managing stress